Skip to main content

Table 4 Estimated Distribution of varicella costs (€) in Europe by age group and health care resource in absence of UVV

From: Economic burden of varicella in Europe in the absence of universal varicella vaccination

Age group

Primary care visits

Hospitalizations

Prescriptions

OTC medications

Work loss caregivers

Work loss patients

Work loss deaths

Proportion of total cost

<5y

€ 51,939,569

€ 29,121,301

€ 18,648,121

€ 20,541,844

€ 193,314,712

NA

NA

47.32%

5-9y

€ 30,605,288

€ 8,138,576

€ 10,516,603

€ 11,741,757

€ 105,800,000

NA

NA

25.17%

10-14y

€ 7,830,211

€ 2,117,755

€ 2,853,437

€ 826,043

€ 24,659,029

NA

NA

5.78%

15-19y

€ 2,936,218

€ 1,940,903

€ 1,071,301

€ 585,661

€ 8,938,000

NA

NA

2.34%

20-39y

€ 7,259,423

€ 9,407,695

€ 2,517,461

€ 1,362,976

NA

€ 75,435,180

€ 57,955

14.49%

40-64y

€ 2,413,798

€ 3,123,022

€ 961,981

€ 615,262

NA

€ 25,146,631

€ 164,349

4.89%

Total

€ 102,984,507

€ 53,849,251

€ 36,568,905

€ 35,673,544

€ 332,711,741

€ 100,581,811

€ 222,303

100.00%